ArticleJAMA neurology2023

Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

Jeffrey A Cohen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.